Markets:

Overview

News

Currencies

International

Treasuries

Applied Therapeutics, Inc. - Common Stock (NQ:APLT)

0.1030 UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Applied Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Regulatory Setback For Applied Therapeutics' Lead Program, FDA Highlights Deficiencies In Clinical Application ↗

November 29, 2024

FDA rejected Applied Therapeutics' Govorestat for galactosemia, citing NDA deficiencies. The company plans discussions for resubmission or appeal.

Via Benzinga

Steelcase Reports Weak Sales, Joins American Healthcare REIT And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

September 19, 2024

Via Benzinga

Dow Jumps Over 100 Points; Fed Cuts Interest Rates By 0.5% ↗

September 18, 2024

Via Benzinga

Topics Economy Stocks

Crude Oil Moves Lower; PowerFleet Shares Spike Higher ↗

September 18, 2024

Via Benzinga

Russell 2000 Outpaces S&P 500 As Small Caps Anticipate Fed's Interest Rate Move ↗

September 18, 2024

Small-cap stocks are surging ahead of the expected interest rate cut by the Federal Reserve, outperforming their larger-cap counterparts. However, potential for gains may be hindered by sluggish...

Via Benzinga

Topics Economy Stocks

Why Applied Therapeutics Stock Is Skyrocketing Today ↗

September 18, 2024

Investors are cheering good news from the FDA.

Via The Motley Fool

Applied Therapeutics: Q4 Earnings Insights ↗

March 06, 2024

Via Benzinga

(APLT) - Analyzing Applied Therapeutics's Short Interest ↗

January 25, 2024

Via Benzinga

Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder Drug ↗

September 18, 2024

Applied Therapeutics stock rises as the FDA no longer requires an Advisory Committee meeting, keeping the Priority Review on track, with the PDUFA target date set for November 28.

Via Benzinga

Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday ↗

September 18, 2024

Via Benzinga

Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket ↗

September 12, 2024

Via Benzinga

Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside ↗

July 31, 2024

William Blair has initiated coverage on Applied Therapeutics highlighting its focus on rare diseases such as galactosemia, SORD deficiency, and diabetic cardiomyopathy. With govorestat (AT-007) poised...

Via Benzinga

CrossFirst Bankshares Posts Q2 Earnings, Joins Owens & Minor, Reddit And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 16, 2024

Via Benzinga

Top 4 Health Care Stocks That May Keep You Up At Night This Month ↗

June 11, 2024

Via Benzinga

APLT Stock Earnings: Applied Therapeutics Meets EPS, Misses Revenue for Q1 2024 ↗

May 09, 2024

APLT stock results show that Applied Therapeutics met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

FDA Presses Delay Button For Applied Therapeutics' First Potential Marketed Drug For Rare Disease ↗

April 01, 2024

FDA extends the review period for Applied Therapeutics' NDA for govorestat, targeting Classic Galactosemia treatment. The new action date is set for November 28, 2024. Applied Therapeutics anticipates...

Via Benzinga

Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket ↗

April 01, 2024

Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 01, 2024

Via Benzinga

Oxford Industries Posts Weak Results, Joins Applied Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

April 01, 2024

U.S. stock futures were higher this morning, with the Dow futures gaining by over 100 points on Monday.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 29, 2024

Via Benzinga

EQT, Genie Energy And Other Big Stocks Moving Lower On Monday ↗

March 11, 2024

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.

Via Benzinga

Topics Stocks

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 28, 2024

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

Via Benzinga

Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday ↗

February 28, 2024

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Wednesday.

Via Benzinga

Topics Stocks

FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder ↗

February 28, 2024

Applied Therapeutics surges as FDA grants Priority Review to govorestat (AT-007) for Galactosemia treatment. If approved, it would be the first medication for Galactosemia. APLT also submits MAA to...

Via Benzinga

Why Is Coupang (CPNG) Stock Up 4% Today? ↗

February 28, 2024

Coupang stock is rallying on Wednesday as investors in CPNG celebrate the company beating out EPS and revenue estimates for Q4.

Via InvestorPlace

Why Is Applied Therapeutics (APLT) Stock Up 59% Today? ↗

February 28, 2024

Applied Therapeutics stock is rising higher on Wednesday alongside heavy trading of APLT following an update from the FDA.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 16, 2024

Via Benzinga

Why Is Rare Disease-Focused Applied Therapeutics Stock Trading Higher Today? ↗

February 15, 2024

Results of Applied Therapeutics' Phase 3 INSPIRE trial for oral govorestat (AT-007). Govorestat demonstrates significant sorbitol reduction, improving mobility and overall well-being in SORD Deficiency...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 15, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Applied Therapeutics, Inc. - Common Stock (NQ:APLT)

Headline News about Applied Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today